HL237

· Hanlim Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HL237, covering 2020-11-20 to 2020-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Clinical Trial of HL237 for Rheumatoid Arthritis [Phase 2]